My ePortfolio Register   
Filter results by:

Showing: Treatments / Targeted molecules

Conference Report: Highlights from the ecancer Future Horizons in Lung Cancer conference, 1–2 September 2016: Focusing on the future of treatment for NSCLC and SCLC

Abstract | Full Article | PDF Published: 23 Mar 2017 / DOI: 10.3332/ecancer.2017.729

Research: Circulating and tissue biomarkers in early-stage non-small cell lung cancer

Abstract | Full Article | PDF Published: 31 Jan 2017 / DOI: 10.3332/ecancer.2017.717

Review: An Australasian perspective on the curative treatment of patients with pancreatic cancer, supportive care, and future directions for management

Abstract | Full Article | PDF Published: 07 Dec 2016 / DOI: 10.3332/ecancer.2016.700

Special Issue: Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

Abstract | Full Article | PDF Published: 28 Oct 2016 / DOI: 10.3332/ecancer.2016.684

Conference Report: Highlights from the 2016 WIN Symposium, 27–29 June 2016, Paris: personalised therapy beyond next-generation sequencing

Abstract | Full Article | PDF Published: 24 Aug 2016 / DOI: 10.3332/ecancer.2016.669

Review: Role of nanotechnology and gene delivery systems in TRAIL based therapies

Abstract | Full Article | PDF Published: 01 Aug 2016 / DOI: 10.3332/ecancer.2016.660

Review: Cancer-associated thrombotic microangiopathy

Abstract | Full Article | PDF Published: 28 Jun 2016 / DOI: 10.3332/ecancer.2016.649

Review: The steady progress of targeted therapies, promising advances for lung cancer

Abstract | Full Article | PDF Published: 28 Apr 2016 / DOI: 10.3332/ecancer.2016.638

Review: Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases

Abstract | Full Article | PDF | Spanish Published: 11 Apr 2016 / DOI: 10.3332/ecancer.2016.632

Review: Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments

Abstract | Full Article | PDF Published: 08 Mar 2016 / DOI: 10.3332/ecancer.2016.626



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence